Menlo Park, CA, United States of America

Gary J Kurtzman

USPTO Granted Patents = 20 

Average Co-Inventor Count = 3.0

ph-index = 14

Forward Citations = 756(Granted Patents)


Location History:

  • Villanova, PA (US) (2000 - 2002)
  • Menlo Park, CA (US) (1998 - 2010)
  • Bryn Mawr, PA (US) (2006 - 2010)

Company Filing History:


Years Active: 1998-2010

Loading Chart...
20 patents (USPTO):Explore Patents

Title: Innovations in Gene Delivery: The Patents of Gary J. Kurtzman

Introduction

Gary J. Kurtzman, based in Menlo Park, CA, is a distinguished innovator known for his significant contributions in the field of gene therapy and treatment methodologies. He holds a remarkable portfolio of 20 patents, demonstrating his commitment to advancing medical technology, particularly in the treatment of anemia through innovative gene delivery systems.

Latest Patents

Among Kurtzman's latest patents are pivotal inventions focusing on the methods of treating anemia using recombinant adeno-associated virus (AAV) virions. These inventions disclose systems for the delivery of DNA molecules to muscle cells and tissues, which allow for both direct, in vivo injection of recombinant AAV virions into muscle tissue and in vitro transduction of muscle cells. The technology enables sustained, high-level expression of erythropoietin, with consequent in vivo secretion from transduced muscle cells, facilitating systemic delivery and offering promising therapeutic outcomes in anemia treatment.

Career Highlights

Throughout his career, Gary J. Kurtzman has made significant strides in the biotech field while affiliated with reputable institutions such as Avigen, Inc. and The Johns Hopkins University. His innovations reflect a dedication to improving patient care through advanced medical solutions, significantly impacting the efficacy of treatments available today.

Collaborations

Kurtzman has collaborated with esteemed colleagues, including Gregory M. Podsakoff and Paul D. Kessler, who have contributed to the success and advancement of his innovative projects. These partnerships exemplify the collaborative spirit of research and development within the scientific community.

Conclusion

Gary J. Kurtzman's contributions through his inventions and patents continue to shape the landscape of gene therapy and medical innovations. His work not only highlights the potential of recombinant adeno-associated viruses in treating anemia but also underscores the importance of collaboration and ingenuity in advancing medical science. With a dedicated focus on enhancing patient outcomes, Kurtzman's innovations are paving the way for future breakthroughs in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…